3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Pulmonary Embolism
1
Pneumothorax
1
Pleural Effusion
1
Pleural Diseases
1
Lung Neoplasms
1
Interventions
Dalteparin
9
apixaban
7
Tinzaparin
5
Enoxaparin
5
Rivaroxaban
3
Dabigatran
3
Warfarin
2
Heparin, Low-Molecular-Weight
2
Fondaparinux
2
perflutren
1
enoxaparin sodium
1
edoxaban
1
bemiparin
1
Sulfur Hexafluoride
1
Rosuvastatin Calcium
1
Phenprocoumon
1
Nephrectomy
1
Nadroparin
1
Hospitals
1
Heparin
1
Fluorodeoxyglucose F18
1
Educational Status
1
Deoxyribonucleases
1
Aspirin
1
Acenocoumarol
1
4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Pulmonary Embolism
×
Deoxyribonucleases
×
Clear all
NCT03167281
2025-02-21
ELEVATE
Prisma Health-Midlands
Phase 4
Withdrawn